Upgrade to SI Premium - Free Trial

Cantor Fitzgerald Downgrades Esperion Therapeutics (ESPR) to Neutral

May 1, 2026 8:38 AM
Cantor Fitzgerald analyst Kristen Kluska downgraded Esperion Therapeutics (NASDAQ: ESPR) ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst PT Change Downgrades